Pfizer and Allergan on Monday morning announced they would merge in a massive, $160 billion deal that will create the world's largest drugmaker, producing treatments as varied as Lipitor and Botox.
The deal is structured as a reverse-merger, with smaller Dublin-based Allergan buying U.S.-based Pfizer, and it is likely to renew concern in the United States over "inversions," where U.S. companies are bought by or merge with foreign firms in order to reduce U.S. corporate tax burdens. Just days a...
16:16 Luxottica, Essilor $24 billion merger creates eyewear giant10
16:42 House follows Senate to approve first step toward repealing Obamacare9
11:00 Morning Agenda: ‘Altaba,’ Taxes of Trump Appointees, Executive Trip Aids F.B.I33
07:24 Burberry's CEO designate to join firm this month19